Commentary

Making cystoscopy accessible in gynecology


 

References

The Cystosure catheter is based on the design of the standard Foley catheter but adds a fourth port (purple ring) where a scope can be inserted for cystoscopy. Courtesy Emmy Medical

The Cystosure catheter is based on the design of the standard Foley catheter but adds a fourth port (purple ring) where a scope can be inserted for cystoscopy.

Yet, while the technique is simple and cheap, it is far from precise and may be misleading. It provides for a fast fill of the bladder in that water enters the bladder as fast as gravity allows. The rapid infusion can sometimes cause an artifact in the patient’s sensation – a significant feeling of pressure or fullness that is premature.

The more-sophisticated technique, multichannel urodynamics, pumps fluid at a slower, controlled rate and provides more accurate information. Yet, it requires expensive equipment, more time, and special expertise. It has not been universally accessible and relevant to the ob.gyn.’s office.

Cystosure bridges the gap between the accurate but costly multichannel urodynamics and the simple but less accurate fast-fill testing method. The nurse can place the Cystosure catheter, attach IV tubing to the inflow port, and then control the drip rate, emulating the pump of the complex urodynamics equipment. When the patient indicates fullness and the overactive bladder/incontinence evaluation is completed, the physician may immediately proceed with simple diagnostic cystoscopy without any further urethral manipulation.

The system can also be coupled to an LED-based battery light source and/or attached to a smartphone/iPad, so that cystoscopy can be performed in any room or at bedside without large bulky equipment and cords. Images and video can be saved and shared from remote locations or used for documentation or teaching.

Dr. Kohli is medical director of Boston Urogyn in Wellesley, Mass., an ob.gyn. staff member at Brigham and Women's Hospital/Newton Wellesley Hospital, and assistant professor of ob.gyn. at Harvard Medical School in Boston. He serves as chief medical officer at Emmy Medical, Holliston, Mass., which manufactures Cystosure.

Pages

Recommended Reading

Debunking five myths about minilaparoscopy
MDedge ObGyn
Which is the more effective treatment for uncomplicated skin infections—clindamycin or trimethoprim-sulfamethoxazole?
MDedge ObGyn
Individualizing treatment of menopausal symptoms
MDedge ObGyn
FDA panel set to vet Essure safety
MDedge ObGyn
Vulvar intraepithelial neoplasia: Changing terms and therapy trends
MDedge ObGyn
ACOG seeks to increase LARC acceptance
MDedge ObGyn
Developing alternatives to unprotected power morcellation
MDedge ObGyn
Letrozole doesn’t cut multiple births compared to standard therapy
MDedge ObGyn
Annual chlamydia screening fails to show significant benefit
MDedge ObGyn
Cystoscopies are us
MDedge ObGyn

Related Articles

  • Commentary

    Cystoscopies are us

    In this edition of the Master Class in Gynecologic Surgery, I have asked urogynecologist Dr. Neeraj Kohli to discuss the use of cystoscopy in...